ClinicalTrials.Veeva

Menu

Analgesia After Cesarean Section

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Preeclampsia
Pregnancy

Treatments

Drug: Magnesium Sulphate

Study type

Observational

Funder types

Other

Identifiers

NCT01360060
Mg_section

Details and patient eligibility

About

Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

Enrollment

503 patients

Sex

Female

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • parturients undergoing Cesarean section

Trial design

503 participants in 2 patient groups

Group N
Description:
parturients who had undergone Cesarean section under the diagnosis of non-preeclampsia
Group P
Description:
parturients who had undergone Cesarean section under the diagnosis of preeclampsia
Treatment:
Drug: Magnesium Sulphate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems